Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

Clinical trial NCT04710498 · COMPLETED

Trial details

NCT number: NCT04710498
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma

Start date: 2021-06-22
Primary completion: 2024-02-07
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.